期刊文献+

扩张型心肌病致病基因LMNA新突变E82K的发现及其功能的初步研究 被引量:6

A novel LMNA gene mutation E82K associated with familial dilated cardiomyopathy
原文传递
导出
摘要 目的检测中国人家族性扩张型心肌病核纤层蛋白A(Lamin A)基因(LMNA)突变情况并初步探索突变基因功能。方法(1)用基因测序的方法扫描1个中国人扩张型心肌病家系(50名成员)LMNA基因的12个外显子,对照为60例正常志愿者。(2)构建野生及突变LMNA基因的真核表达载体并分别转染HEK293细胞后,用0.8mmol/L过氧化氢刺激24h,观察各组细胞凋亡率的差异。结果(1)该家系先证者LMNA基因第1号外显子第244位碱基位置发生G→A转换,其编码氨基酸由谷氨酸(E)变为赖氨酸(K)。(2)给予0.8mmol/L过氧化氢刺激24h后,转染突变LMNA基因表达载体的细胞组凋亡率(29.13±1.24)%显著高于其他细胞组(P<0.01)。结论携带LMNA基因E82K错义突变的患者临床表型呈现症状重、发病早、预后差的临床特点,且部分患者合并Ⅱ°~Ⅲ°房室传导阻滞,该突变所促进的细胞凋亡可能是导致扩张型心肌病的原因之一。 Objective To examine the function of the novel mutation E82K in LMNA gene identified in a Chinese family infected by dilated cardiomyopathy. Methods (1) One Chinese family infected by dilated cardiomyopathy was chosen for the study. Exons 1-12 of the LMNA gene were screened with both PCR method and the cycle sequencing of the PCR products. (2) cDNA of the E82K mutation or wild type of LMNA gene was transfected into HEK293 cells and the apoptosis of the cells was detected after treatment with 0. 8 mmol/L H2O2. Results ( 1 ) A new mutation E82K in LMNA gene was identified in this dilated cardiomyopathy family. (2) Apoptosis was more in the HEK293 cells transfected with E82K mutation than those with empty vector or wild type LMNA gene. Conclusions The missense mutation E82K in LMNA gene changed the polar of the amino acid. It showed a malignant phenotype of severe clinical symptoms, early onset, poor survival prognosis and might be associated with atrioventricular conduction block ( Ⅱ°-Ⅲ°), suggesting that the E82K mutation in LMNA gene may be a candidate for nosogenesis of dilated cardiomyopathy.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2005年第10期875-879,共5页 Chinese Journal of Cardiology
基金 北京市重大自然科学基金资助项目(7040001)
关键词 心肌病 充血性 突变 LMNA Cardiomyopathy, congestive Mutation LMNA
  • 相关文献

参考文献17

  • 1Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.Circulation,1996,93:841-842.
  • 2Komajda M, Jais J, Reeves F, et al. Factors predicting mortality in idiopathic dilated cardiomyopathy.Eur Heart J,1990,11:824-831.
  • 3Codd MB, Sugrue DD, Gersh BJ, et al. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984.Circulation, 1989, 80:564-572.
  • 4Kasper EK, Agema WR, Hutchins GM, et al. The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients.J Am Coll Cardiol,1994,23:586-590.
  • 5Fatkin D, MacTae C, Sasaki T, et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease.N Engl J Med,1999,341:1715-1724.
  • 6Gilchrist S, Gilbert N, Perry P, et al. Altered protein dynamics of disease-associated lamin A mutants.BMC Cell Biol,2004,5:46.
  • 7Cao H, Hegele RA. LMNA is mutated in Hutchinson-Gilford progeria (MIM 176670) but not in Wiedemann-Rautenstrauch progeroid syndrome (MIM 264090).J Hum Genet,2003,48:271-274.
  • 8Marina RB, Giluliana G, Pietro T, et al. Different mutation in the LMNA gene cause autosomal dominant and autosomal recessive Emern-Drifuss muscular dystrophy. Am J Hum Genet, 2000, 66:1407-1412.
  • 9Ben Yaou R, Muchir A, Arimura T, et al. Genetics of laminopathies.Novartis Found Symp, 2005,264:81-90.
  • 10Cao H, Hegele RA. Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy.Hum Mol Genet,2000,9:109-112.

同被引文献57

  • 1钟馨.中西医结合治疗慢性阻塞性肺疾病22例[J].实用中医内科杂志,2009,23(10):75-76. 被引量:1
  • 2王志民,邹玉宝,宋雷,马爱群,刘唐威,谷惠敏,卢赛兰,武鹏翥,孙兆明,何国宝,张卫,张颖,沈丽,蔡玉岭,甄一松,刘延玲,惠汝太.超声心动图检查调查8080例成人肥厚型心肌病患病率[J].中华心血管病杂志,2004,32(12):1090-1094. 被引量:59
  • 3王虎,宋晓东,王曙霞,傅春燕,孙凯,惠汝太.扩张型心肌病致病基因LMNA新突变E82K对细胞周期影响的实验研究[J].中华心血管病杂志,2007,35(1):21-23. 被引量:3
  • 4赵水平.临床心血管新理论和新技术[M].长沙:湖南科学技术出版社,2006:168.
  • 5王永炎,沈绍功.今日中医内科[M].上海:上海科学技术出版社,2003:523-563.
  • 6全国心肌炎 心肌病专题研讨会组委会.全国心肌炎心肌病专题研讨会纪要[J].临床心血管病杂志,1995,11:324-326.
  • 7Arber S,Hunter JJ,Ross J Jr,et al.MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization,dilated cardiomyopathy,and heart failure.Cell,1997,88:393-403.
  • 8Cohn RD,Durbeej M,Moore SA,et al.Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex.J Clin Invest,2001,107:R1-R7.
  • 9Azevedo VM,Albanesi Filho FM,Santos MA,et al.The role of L-carnitine in nutritional status and echocardiographic parameters in idiopathic dilated cardiomyopathy in children.J Pediatr (Rio J),2005,81:368-372.
  • 10Richardson P,McKenna W,Bristow M,et al.Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.Circulation,1996,93:841-842.

引证文献6

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部